Stuart Shanler
2018
In 2018, Stuart Shanler earned a total compensation of $1.8M as Chief Scientific Officer at Aclaris Therapeutics, a 239% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $116,400 |
|---|---|
| Option Awards | $937,980 |
| Salary | $400,000 |
| Stock Awards | $342,395 |
| Other | $11,660 |
| Total | $1,808,435 |
Shanler received $938K in option awards, accounting for 52% of the total pay in 2018.
Shanler also received $116.4K in non-equity incentive plan, $400K in salary, $342.4K in stock awards and $11.7K in other compensation.
Rankings
In 2018, Stuart Shanler's compensation ranked 6,239th out of 14,244 executives tracked by ExecPay. In other words, Shanler earned more than 56.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,239 out of 14,244 | 56th |
Division Manufacturing | 2,390 out of 5,765 | 59th |
Major group Chemicals And Allied Products | 893 out of 2,128 | 58th |
Industry group Drugs | 749 out of 1,817 | 59th |
Industry Pharmaceutical Preparations | 582 out of 1,391 | 58th |
Source: SEC filing on April 25, 2019.
Shanler's colleagues
We found two more compensation records of executives who worked with Stuart Shanler at Aclaris Therapeutics in 2018.